• Merck Licenses Four Oncology Research and Development Programs from Vertex americanpharmaceuticalreview
    January 13, 2017
    Merck KGaA, Darmstadt, Germany, a science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA, for the
PharmaSources Customer Service